Showing 1 - 20 results of 21 for search 'C. Lowe', query time: 0.04s
Refine Results
-
1
Manufacturing of High Conductivity, High Strength Pure Copper with Ultrafine Grain Structure by Leila Ladani, Jafar Razmi, Terry C. Lowe
Published 2023-07-01
Article -
2
-
3
Educational Case: Idiopathic Inflammatory Bowel Disease by Carl T. McGary MD, PhD, Maureen C. Lowe MD
Published 2020-07-01
Article -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Investigation of the contribution of an underlying platelet defect in women with unexplained heavy menstrual bleeding by Gillian C. Lowe, Roksana Fickowska, Rashid Al Ghaithi, Annabel Maclachlan, Paul Harrison, Will Lester, Steve P. Watson, Bethan Myers, Justin Clark, Neil V. Morgan
Published 2019-01-01
Article -
12
Impact of Reconstruction on Oncologic Outcomes for Patients with Melanoma after Wide Local Excision: A High-Volume, Quaternary-Referral Center Experience by Michael K. Turgeon, MD, Jeesoo Lee, BS, Keith A. Delman, MD, Michael C. Lowe, MD, Peter W. Thompson, MD, Heather R. Faulkner, MD, MPH
Published 2023-06-01
Article -
13
Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months by Samantha J. Montague, Christopher W. Smith, Clare S. Lodwick, Charlotte Stoneley, Matthew Roberts, Gillian C. Lowe, William A. Lester, Steve P. Watson, Phillip L. R. Nicolson
Published 2022-03-01
Article -
14
Histone H2A ubiquitination resulting from Brap loss of function connects multiple aging hallmarks and accelerates neurodegeneration by Yan Guo, Alison.A. Chomiak, Ye Hong, Clara C. Lowe, Caroline A. Kopsidas, Wen-Ching Chan, Jorge Andrade, Hongna Pan, Xiaoming Zhou, Edwin S. Monuki, Yuanyi Feng
Published 2022-07-01
Article -
15
-
16
622 Immune phenotype and iFRET functional analysis are biomarkers of response to neoadjuvant intralesional therapy for high risk stage II melanoma by Sunil Reddy, Susan Swetter, Emanual Maverakis, Mohammad Usman Ahmad, Michael C Lowe, Saurabh Sharma, Mamatha Serasanambati, Chris Applebee, Elena Safrygina, Banafshe Larijani, Amanda Kirane, Allison B Warner
Published 2023-11-01Article -
17
Impact of concomitant fibrates on immunotherapy outcomes for advanced non‐small cell lung cancer by William A. Stokes, Madhusmita Behera, Renjian Jiang, David A. Gutman, Zhonglu Huang, Abigail Burns, Nikhil T. Sebastian, Vidula Sukhatme, Michael C. Lowe, Suresh S. Ramalingam, Vikas P. Sukhatme, Drew Moghanaki
Published 2023-01-01
Article -
18
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis by Haydn Kissick, Viraj A Master, Mehmet A Bilen, Zachary S Buchwald, Mohammad K Khan, Caroline S Jansen, Michael C Lowe, Jimmy S Patel, Yena Woo, Amber Draper, Jennifer W Carlisle, Pasquale F Innominato, Francis A Lévi, Layla Dhabaan, David C Qian
Published 2024-03-01
Article -
19
629 Neoadjuvant SEMA4D inhibitor pepinemab combination with nivolumab increases crosstalk between B cell and CD26hi T cell in patients with resectable stage III melanoma by Brian Burns, Elizabeth Evans, Ragini Kudchadkar, Crystal Mallow, Christine Reilly, Maurice Zauderer, Gregory B Lesinski, Keith A Delman, Chrystal M Paulos, Brian Olson, Terrence Fisher, Jayden Kim, Michael C Lowe, Ayana T Ruffin, Jacklyn Hammons, Agnes Harutyunyan, Melinda Yushak, Ali Mokhtari, Douglas Parker
Published 2023-11-01Article -
20
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction by Elizabeth England, D. Gareth Rees, Ian Christopher Scott, Sara Carmen, Denice T. Y. Chan, Catherine E. Chaillan Huntington, Kirsty F. Houslay, Teodor Erngren, Mark Penney, Jayesh B. Majithiya, Laura Rapley, Dorothy A. Sims, Claire Hollins, Elizabeth C. Hinchy, Martin D. Strain, Benjamin P. Kemp, Dominic J. Corkill, Richard D. May, Katherine A. Vousden, Robin J. Butler, Tomas Mustelin, Tristan J. Vaughan, David C. Lowe, Caroline Colley, E. Suzanne Cohen
Published 2023-06-01
Article